DE69924003D1 - Medizinische verwendung eines gens und eines vektors, der eine multisubstrat-desoxyribonukleosidase kodiert - Google Patents

Medizinische verwendung eines gens und eines vektors, der eine multisubstrat-desoxyribonukleosidase kodiert

Info

Publication number
DE69924003D1
DE69924003D1 DE69924003T DE69924003T DE69924003D1 DE 69924003 D1 DE69924003 D1 DE 69924003D1 DE 69924003 T DE69924003 T DE 69924003T DE 69924003 T DE69924003 T DE 69924003T DE 69924003 D1 DE69924003 D1 DE 69924003D1
Authority
DE
Germany
Prior art keywords
desoxyribonucleosidase
multisubstrate
gene
cell
medical use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69924003T
Other languages
English (en)
Other versions
DE69924003T2 (de
Inventor
Anna Karlsson
Magnus Johansson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZGENE AS LYNGBY
Original Assignee
ZGENE AS LYNGBY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZGENE AS LYNGBY filed Critical ZGENE AS LYNGBY
Publication of DE69924003D1 publication Critical patent/DE69924003D1/de
Application granted granted Critical
Publication of DE69924003T2 publication Critical patent/DE69924003T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE69924003T 1998-12-11 1999-12-10 Medizinische verwendung eines gens und eines vektors, der eine multisubstrat-desoxyribonukleosidase kodiert Expired - Lifetime DE69924003T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9804298A SE9804298D0 (sv) 1998-12-11 1998-12-11 New medical use
SE9804298 1998-12-11
PCT/SE1999/002314 WO2000036099A1 (en) 1998-12-11 1999-12-10 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase

Publications (2)

Publication Number Publication Date
DE69924003D1 true DE69924003D1 (de) 2005-04-07
DE69924003T2 DE69924003T2 (de) 2006-04-13

Family

ID=20413633

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69924003T Expired - Lifetime DE69924003T2 (de) 1998-12-11 1999-12-10 Medizinische verwendung eines gens und eines vektors, der eine multisubstrat-desoxyribonukleosidase kodiert

Country Status (9)

Country Link
US (1) US6582947B1 (de)
EP (1) EP1137764B1 (de)
JP (1) JP2002532090A (de)
AT (1) ATE290071T1 (de)
AU (1) AU778376B2 (de)
DE (1) DE69924003T2 (de)
ES (1) ES2239475T3 (de)
SE (1) SE9804298D0 (de)
WO (1) WO2000036099A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003533225A (ja) * 2000-05-12 2003-11-11 クネヒト・ヴォルフガング 新規デオキシリボヌクレシドキナーゼ酵素の多基質変異体
WO2003100045A1 (en) 2002-05-23 2003-12-04 Wolfgang Knecht Plant thymidine kinases and their use
US20070202120A1 (en) * 2003-07-11 2007-08-30 Zgene A/S Yellow Fever Mosquito Deoxyribonucleoside Kinases And Its Use
JP5211303B2 (ja) * 2007-10-25 2013-06-12 独立行政法人産業技術総合研究所 蛋白質の製造方法
CN116479068B (zh) * 2023-05-08 2023-11-21 汇海(苏州)生物技术有限公司 一种利用生物酶制备n1-甲基-假尿苷单磷酸的方法

Also Published As

Publication number Publication date
AU778376B2 (en) 2004-12-02
DE69924003T2 (de) 2006-04-13
ATE290071T1 (de) 2005-03-15
SE9804298D0 (sv) 1998-12-11
WO2000036099A1 (en) 2000-06-22
EP1137764A1 (de) 2001-10-04
US6582947B1 (en) 2003-06-24
EP1137764B1 (de) 2005-03-02
ES2239475T3 (es) 2005-09-16
JP2002532090A (ja) 2002-10-02
AU2018500A (en) 2000-07-03

Similar Documents

Publication Publication Date Title
KR950702626A (ko) 치료제로서 자체-안정화된 올리고누클레오티드(self-stabilized loigonucleotides as therapeutic agents)
GR3020557T3 (en) Oligonucleotide alkylphosphonates and alkylphosphonothioates.
MY117686A (en) Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
AU658634B2 (en) Synthetic catalytic oligonucleotide structures containing modified nucleotides
DE69434820D1 (de) Nukleinsäurevektor, einen solchen vektor enthaltene verbindung und impfstoff zur immunisierung gegen hepatitis
EP0638121A1 (de) Gezielte spaltung von rna mittels eukaryontischer rnase p und externe führungssequenz.
AU2022295A (en) Nucleic acid amplification with DNA-dependant RNA polymerase activity of RNA replicases
WO2000003030A3 (en) Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
ATE216705T1 (de) Antisense-oligonukleotidmodulation der raf- genexpression
HUP9904203A2 (hu) Eljárás hosszú, ismétlődő DNS-szekvenciák stabil klónozására
MY117628A (en) Process of treating a stainless steel matrix
DK1175489T3 (da) Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider
HUP0101991A2 (hu) Peszticid toxinok és az ezeket kódoló nukleotid szekvenciák
DE69924003D1 (de) Medizinische verwendung eines gens und eines vektors, der eine multisubstrat-desoxyribonukleosidase kodiert
Katanaev et al. Viral Qβ RNA as a high expression vector for mRNA translation in a cell‐free system
WO1999028439A3 (fr) Erythrovirus et ses applications
BR9815285A (pt) Vetores alfavìrus para vacina de paramixovìrus
ES2168459T3 (es) Secuencias amplificadoras derivadas del gen de la desmina, vectores que llevan estas secuencias y sus utilizaciones para la produccion de proteinas.
Yi et al. Human endogenous retroviral elements belonging to the HERV-S family from human tissues, cancer cells, and primates: expression, structure, phylogeny and evolution
ATE223492T1 (de) Mutanten des infektiösen rinder rhinotracheitis- virus und impfstoffe
FR2701960B1 (fr) Polyribozyme apte à conférer, aux plantes, une résistance aux virus et plantes résistantes produisant ce polyribozyme.
DE60028217D1 (de) Zyklische depsipeptid-synthasen, deren gene und system zur massenproduktion von zyklischen depsipeptiden
WO1999057284A3 (en) Attenuated influenza viruses
PT1254663E (pt) Agente antiviral
DE60334222D1 (en) Adenovirusvektor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition